Gotham Makker - 13 Jun 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact
Issuer symbol
RCKT
Transactions as of
13 Jun 2024
Net transactions value
+$40,006
Form type
4
Filing time
20 Jun 2024, 16:10:24 UTC
Previous filing
25 Mar 2024
Next filing
29 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +23,944 $0.000000 23,944 13 Jun 2024 Common Stock 23,944 $22.86 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $40,006 +2,660 $15.04 2,660 13 Jun 2024 Common Stock 2,660 $22.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025.
F2 This option represents a right to purchase a total of 2,660 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025. This option was issued to the Reporting Person in lieu of director retainer fees of $40,000.